[1]World Health Organization. Global tuberculosis control report 2012.Geneva:WHO,2012[2012-12-08].http://apps.who.int/iris/bitstream/10665/75938/1/9789241564502_eng.pdf.[2]吴启秋.对骨关节结核手术适应证的认识.结核病与胸部肿瘤,1998,(2):1-3.[3]戈朝晖,王自立,魏敏吉. 脊柱结核病灶中抗痨药物浓度的测定.中华骨科杂志,2004,25(2),97-101.[4]Lloyd AW. Interfacial bioengineering to enhance surface biocompatibility. Med Device Technol,2002,13(1):18-21.[5]Buchholz HW, Engelbrecht H. Depot effects of various anti-biotics mixed with Palacos resins.Chirurg,1970,41(11): 511-515.[6]牛惠生,李怀芬,叶文忠,等.缓释植入型抗结核药异烟肼明胶海绵的实验研究.天津药学,1992,4(3):7-10.[7]孟晓林,时和同. 缓释抗结核药佐治脊柱结核合并巨大冷脓肿. 蚌埠医学院学报,2001,26(2):148.[8]Fujibayashi S, Senaha Y, Yoshihara S,et al. Long-term follow-up study of bioactive bone cement for repairing a segmental defect in a canine femur.J Long Term Eff Med Implants,2001,11(1/2):93-103.[9]陈安民,孙淑珍.利福平—陶瓷人工骨核(R-PHA)治疗骨结核的实验研究与临床应用.中华骨科杂志,1992,12(1):18-22.[10]秦世炳,董伟杰,范俊,等. 医用硫酸钙颗粒在骨关节结核治疗中的应用探讨. 结核病与胸部肿瘤,2006,(2):103-106.[11]Hsu YY,Gresser JD,Stewart RR,et al.Mechanisms of isoniazid release from poly(d,1-laetide-co-glycoliole)matrics prepared by dry-mixing and low density polymeric foam methods.J Pharm Sci,1996, 85(7):706-713.[12]Kailasam S,Daneluzzi D,Gangadharam PR.Maintenance of therapeutically active levels of isoniazid for prolonged periods in rabbits after a single implant of biodegradable polymer.Tuber Lung Dis,1994,75(5):361-365.[13]李大伟, 马远征,杨飞,等.β-磷酸三钙/聚乳酸-聚羟基乙酸/异烟肼缓释材料制备与分析.中国防痨杂志,2013,35(5):309-313.[14]张宏其,高琪乐,郭虎兵,等. 人同种异体骨载异烟肼-壳聚糖缓释微球的制备和体内外释药特性. 中国组织工程研究,2012,16(3):479-483. |